Resistance to Ceftazidime/Avibactam in <i>Klebsiella pneumoniae</i> KPC-Producing Isolates: A Real-Life Observational Study

Resistance to Ceftazidime/Avibactam in <i>Klebsiella pneumoniae</i> KPC-Producing Isolates: A Real-Life Observational Study

<b>Background:</b> Ceftazidime/avibactam (CAZ-AVI) resistance amongst <i>Enterobacterales</i> is worryingly increasing worldwide. <b>Objectives:</b> The aim of this study was to collect and describe real-life data on CAZ-AVI-resistant <i>Klebsiella pneumonia...

Full description

Bibliographic Details
Main Authors:	Laura Campogiani, Pietro Vitale, Alessandra Lodi, Alessandra Imeneo, Carla Fontana, Cartesio D’Agostini, Mirko Compagno, Luigi Coppola, Ilaria Spalliera, Vincenzo Malagnino, Elisabetta Teti, Marco Iannetta, Massimo Andreoni, Loredana Sarmati
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Antibiotics
Subjects:	<i>Klebsiella pneumoniae</i> ceftazidime/avibactam multidrug resistance
Online Access:	https://www.mdpi.com/2079-6382/12/5/820

Similar Items

The <i>Klebsiella pneumoniae</i> carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam
by: Sona Garsevanyan, et al.
Published: (2023-12-01)

Ceftazidime-avibactam susceptibility among KPC-producing enterobacterales in southern Brazil
by: Natália Kehl Moreira, et al.
Published: (2023-11-01)

Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> subsp. <i>pneumoniae</i> Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance
by: Carla Fontana, et al.
Published: (2021-11-01)

Cost-Effectiveness of Short Course of Ceftazidime/Avibactam for <i>K. pneumoniae</i>-KPC Bloodstream Infections in Italy
by: Ilaria De Benedetto, et al.
Published: (2023-04-01)

In vitro effectiveness of ceftazidime-avibactam in combination with aztreonam on carbapenemase-producing Enterobacterales
by: Papa-Ezdra Romina, et al.
Published: (2023-12-01)

Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature
by: Alessandro Mancuso, et al.
Published: (2023-08-01)

Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant Klebsiella pneumoniae Strains
by: Yuchen Wu, et al.
Published: (2022-04-01)

Emergence of KPC-134, a KPC-2 variant associated with ceftazidime-avibactam resistance in a ST11 Klebsiella pneumoniae clinical strain
by: Xiangning Huang, et al.
Published: (2023-10-01)

In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea
by: Taeeun Kim, et al.
Published: (2020-12-01)

Community-acquired bacteraemia by Klebsiella pneumoniae producing KPC-3 and resistant to ceftazidime/avibactam
by: Isabel Machuca, et al.
Published: (2022-09-01)

KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97
by: María Belén Sanz, et al.
Published: (2024-03-01)

Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo
by: Zeyu Huang, et al.
Published: (2023-11-01)

Whole-Genome Sequencing and Molecular Analysis of Ceftazidime–Avibactam-Resistant KPC-Producing <i>Klebsiella pneumoniae</i> from Intestinal Colonization in Elderly Patients
by: Giulia Errico, et al.
Published: (2023-08-01)

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing <i>Klebsiella pneumoniae</i>
by: Li Ding, et al.
Published: (2022-04-01)

The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in Zhejiang Province, China
by: Congcong Liu, et al.
Published: (2022-05-01)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01)

Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae
by: Venditti C, et al.
Published: (2019-07-01)

Isolation of a Ceftazidime-Avibactam-Resistant blaKPC-71-Positive Klebsiella pneumoniae Clinical Isolate
by: Siquan Shen, et al.
Published: (2022-02-01)

In Vitro Susceptibility of <i>Burkholderia pseudomallei</i> Isolates to Cefiderocol and Ceftazidime/Avibactam from Odisha, India
by: Jayanti Jena, et al.
Published: (2023-12-01)

Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam
by: Siquan Shen, et al.
Published: (2022-12-01)

Native mitral valve endocarditis associated with KPC producing Serratia marcescens bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam
by: Alwin Tilanus, et al.
Published: (2021-01-01)

Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature
by: Ángela Cano, et al.
Published: (2020-09-01)

In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula
by: Ágnes Sonnevend, et al.
Published: (2020-10-01)

In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)

Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain
by: Yuexing Tu, et al.
Published: (2022-02-01)

Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro
by: Qiuxia Lin, et al.
Published: (2021-02-01)

A Selective Medium for Screening Ceftazidime/Avibactam Resistance in Carbapenem-Resistant Enterobacterales
by: Weiliang Zeng, et al.
Published: (2022-07-01)

Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant Enterobacterales: A Multi-Center Study in Southwest China
by: Sun S, et al.
Published: (2022-04-01)

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing <i>Klebsiella pneumoniae</i> in ICU Setting: We Are What We Are Treated with?
by: Silvia Corcione, et al.
Published: (2023-03-01)

Phenotypic and Genetic Analysis of KPC-49, a KPC-2 Variant Conferring Resistance to Ceftazidime–Avibactam and Maintaining Resistance to Imipenem and Meropenem
by: Yu M, et al.
Published: (2023-04-01)

Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
by: Zahra Goudarzi, et al.
Published: (2023-07-01)

Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
by: Basem M. Alraddadi, et al.
Published: (2019-09-01)

Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China
by: Xi Li, et al.
Published: (2021-08-01)

First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing <i>Klebsiella pneumoniae</i> Strain from Portugal
by: Gabriel Mendes, et al.
Published: (2022-01-01)

Ceftazidime-Avibactam Treatment for <i>Klebsiella pneumoniae</i> Bacteremia in Preterm Infants in NICU: A Clinical Experience
by: Andrea Marino, et al.
Published: (2023-07-01)

Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study
by: Meng H, et al.
Published: (2023-09-01)

Resistance to ceftazidime–avibactam and underlying mechanisms
by: Yuhang Wang, et al.
Published: (2020-09-01)

In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates
by: Dan Li, et al.
Published: (2023-12-01)

Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Karoline Knudsen List, et al.
Published: (2022-09-01)